Since the discovery of gonadotropin-releasing hormone (GnRH, also called luteinizing hormone-releasing hormone, LHRH), several GnRH analogs have been developed for treating women with various gynecological conditions, such as uterine fibroids, endometriosis, and central precocious puberty [43]. This evidence concerns the gene GNRH1 and uterine corpus leiomyoma.